Teladoc Health, Inc. (TDOC) Cash flow
Market cap
$909.82M
P/E ratio
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Depreciation & amortization | 5 | 8 | 19 | 36 | - | 69 | 204 | 256 | - | - | - |
| Stock-based compensation | 3 | 8 | 31 | 44 | 67 | 476 | 303 | 218 | 202 | 146 | 80 |
| Cash from operations | -47 | -52 | -34 | -5 | 30 | -54 | 194 | 189 | 350 | 294 | 294 |
| Capital expenditures | -6 | -2 | -3 | -4 | -4 | -4 | -9 | -16 | -11 | -11 | -9 |
| Cash from investing | -108 | 26 | -448 | -257 | 25 | -591 | -73 | -168 | -156 | -124 | -266 |
| Proceeds from issuance of term debt, net | 7 | 35 | 167 | 0 | - | - | - | - | - | - | - |
| Repayments of term debt | 6 | 17 | 226 | - | - | - | - | - | - | - | - |
| Cash from financing | 164 | 21 | 475 | 646 | 35 | 859 | 41 | 6 | 11 | 8 | -552 |
| Free cash flow | |||||||||||
| FCF margin (%) |